25iP-NBOMe, also known as 2C-iP-NBOMe or NBOMe-2C-iP, is a derivative of the phenethylamine hallucinogen 2C-iP, which has been encountered as a novel designer drug.
Toxicity and harm potential
Neurotoxic and cardiotoxic actions
Emergency treatment
Interactions
Pharmacology The interactions of 25iP-NBOMe with the μ-opioid receptor have been described.
History 25iP-NBOMe was first described in the scientific literature by at least 2014, when it was encountered as a novel designer drug.
Society and culture Legal status Canada 25iP-NBOMe is a controlled substance in Canada under phenethylamine blanket-ban language.
United Kingdom
See also 25-NB 2C-iP DOiP
Notes
References
External links 25IP-NBOMe - Isomer Design The Small & Handy 25iP-NBOMe Thread - Bluelight